How levodopa affects iron levels in the brain
Contribution of Levodopa to Brain Iron Accumulation
This study is looking at how the Parkinson's medication levodopa might affect iron levels in the brain, especially in people with Parkinson's Disease, to see if it could play a role in brain cell health.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Pennsylvania State Univ Hershey Med Ctr NIH-funded |
| Lab location | 1 site (Hershey, United States) |
| Project ID | NIH-10901570 on NIH RePORTER |
What this research studies
This research investigates the effects of the antiparkinson drug levodopa (L-DOPA) on iron accumulation in the brain, particularly in patients with Parkinson's Disease (PD). The study aims to understand whether L-DOPA treatment contributes to increased iron levels in the substantia nigra, a critical area affected by PD. Using in vitro models, researchers will explore how L-DOPA influences iron transport across the blood-brain barrier and its impact on brain cell function. This could provide insights into the relationship between L-DOPA treatment and neurodegeneration in PD patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults diagnosed with Parkinson's Disease who are currently receiving or have received L-DOPA treatment.
Not a fit: Patients who are not diagnosed with Parkinson's Disease or those who have never been treated with L-DOPA may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies for Parkinson's Disease by addressing the side effects of L-DOPA related to iron accumulation.
How similar studies have performed: Previous research has indicated that drug treatments can influence iron metabolism in the brain, suggesting that this investigation may yield valuable insights.
Where this research is happening
Hershey, United States
- Pennsylvania State Univ Hershey Med Ctr — Hershey, United States (Active)
Researchers
- Principal investigator: Serpa, Rebecka Oliveira — Pennsylvania State Univ Hershey Med Ctr
- Study coordinator: Serpa, Rebecka Oliveira
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.